IPG Photonics (IPGP) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and IPG Photonics published the results on November 3, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. IPG Photonics reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• From the first quarter of 2026 IPG Photonics reports sales in two application categories, Industrial Solutions and Advanced Solutions, and reclassified prior periods. Micromachining sales moved from Industrial Solutions to Advanced Solutions.
• GAAP results for the first nine months of 2026 include $17.8 million of impairment charges and $14.4 million of litigation settlement and fees, which IPG excludes from its adjusted figures.

Source: IPG Photonics Q3 2026 results, November 3, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How IPG Photonics splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• IPG Photonics's Industrial Solutions revenue was $240 million in Q3 2026, up 12% from $215 million in Q3 2025, 83% of total revenue.
• IPG Photonics's Advanced Solutions revenue was $48.0 million in Q3 2026, up 33% from $36.1 million in Q3 2025, 17% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, IPG Photonics said:

“For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million.”

“IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million.”

“The guidance assumes no contribution from the acquisition of Lumibird Medical.”

Source: IPG Photonics Q3 2026 release, Nov 3, 2026.

This is the company's own guidance as of Nov 3, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the IPGP forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP revenue in millions and GAAP diluted EPS, each as first reported in that quarter's release.

We do not hold a confirmed date for IPG Photonics's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 3, 2026

IPG Photonics sells fiber lasers, laser systems and components, and reports the sales in two application categories. In Q3 2026 Industrial Solutions brought in $239.5 million of the $287.5 million total, 83.3% of revenue, and grew 11.6% on higher sales in welding and additive manufacturing. Advanced Solutions, which covers medical, defense, micromachining, scientific and instrumentation uses, rose 32.8% to $48.0 million on semiconductor and defense sales, partly offset by lower micromachining sales. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026)

By product, lasers and components were $226.0 million, or 78.6% of sales, and systems $61.5 million, up 26.4%. IPG said emerging growth products made up 52% of revenue, down from 58% in the prior quarter because of product mix, and that currency moves added about 1% to revenue. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026; IPG Photonics Q3 2026 release, Nov 3, 2026)

Asia is IPG Photonics' largest region. Asian sales were $138.9 million in the quarter, of which China was $98.5 million, up from $74.1 million a year earlier. North America rose to $82.6 million from $62.0 million, and Europe slipped to $61.9 million from $62.7 million. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026)

IPG Photonics' five largest customers took 20% of net sales in the first nine months of 2026, against 16% for full-year 2025. IPG is vertically integrated, making most key components itself, from semiconductor diodes to optical fiber preforms, which its 10-K says leaves it with high fixed costs when demand falls. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026; IPG Photonics Form 10-K, 2025, Feb 23, 2026)

On September 8, 2026 IPG agreed to buy Lumibird Medical for 300 million euros in cash plus an earn-out of up to 50 million euros, a deal it expects to close in the fourth quarter of 2026 and to add revenue to Advanced Solutions. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026; IPG Photonics Q3 2026 release, Nov 3, 2026)

IPG Photonics earned $0.47 a diluted share on a GAAP basis in Q3 2026 and $0.61 on its adjusted basis. The adjusted figure adds back $2.0 million of amortization of acquired intangibles, a $3.3 million foreign exchange loss, impairment, restructuring and acquisition charges, and discrete tax items of $949 thousand, net of the tax effect of the adjustments. (IPG Photonics Q3 2026 release, Nov 3, 2026)

The tax rate moved a long way. IPG's effective tax rate was 28.7% in Q3 2026 against 52.3% a year earlier, mainly because of smaller adjustments for uncertain tax positions; its non-GAAP tax rate for the quarter was 23%. Gross margin of 40.7% included $5.0 million of net tariff refunds. (IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026; IPG Photonics Q3 2026 release, Nov 3, 2026)

IPG Photonics' diluted share count was 42.8 million, against 42.6 million a year earlier. Buybacks slowed: IPG bought 34,656 shares in the quarter at an average of $76.38 under its February 2026 authorization of up to $100.0 million, against 214,408 shares in Q3 2025. (IPG Photonics Q3 2026 release, Nov 3, 2026; IPG Photonics Form 10-Q, Q3 2026, Nov 3, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

IPG Photonics gives a quarterly range in its release. For Q4 2026 it guided revenue of $265 million to $295 million, adjusted gross margin of 37.0% to 40.0%, adjusted EPS of $0.30 to $0.60 and adjusted EBITDA of $33 million to $50 million, excluding any contribution from Lumibird Medical. (IPG Photonics Q3 2026 release, Nov 3, 2026)

The outlook assumes exchange rates of euro 0.88, Japanese yen 157 and Chinese yuan 6.74 to the dollar. IPG said its Q3 book-to-bill was about one and that trade and tariff uncertainty raises the risk to the outlook. (IPG Photonics Q3 2026 release, Nov 3, 2026)

A consensus figure is the average of the models published by the analysts who cover IPG Photonics, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones IPG Photonics's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning IPGP is on is IPGP a buy or a sell?, what analysts expect next is on the IPGP forecast, and what the company does is on the IPG Photonics (IPGP) stock page.

Every number on this page can be traced to a document IPG Photonics published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.